Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06483373
EARLY_PHASE1
A Clinical Study of SPH7854 Granules in Healthy Subjects.
Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
View on ClinicalTrials.gov
Summary
To evaluate the safety of SPH7854 in healthy subjects.
Official title: A Single and Multiple Dose-escalation, and Food Effects of Phase I Clinical Study to Evaluate the Tolerability/Safety/Pharmacokinetics of SPH7854 Granules in Healthy Subjects.
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
111
Start Date
2024-05-28
Completion Date
2025-12-31
Last Updated
2025-08-17
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
SPH7854
SPH7854: Orally, 50-3200mg
DRUG
Placebo
Placebo:Orally;
Locations (1)
West China Second University Hospital, Sichuan University
Chengdu, China